Ticker: CRSP

Company: CRISPR Therapeutics AG

Person: Douglas A Treco, director

Transaction date: Aug. 6, 2025

Reporting date: Aug. 8, 2025

Average share price: 57.03

Bought 20000.0 shares for 1140600.0